Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2018 (2018), Article ID 9371492, 6 pages
https://doi.org/10.1155/2018/9371492
Research Article

Radical Gastrectomy: Still the Cornerstone of Curative Treatment for Gastric Cancer in the Perioperative Chemotherapy Era—A Single Institute Experience over a Decade

1University of Adelaide Discipline of Surgery, The Queen Elizabeth Hospital, Woodville, Adelaide, SA, Australia
2Division of Surgery, The Queen Elizabeth Hospital, Woodville, Adelaide, SA, Australia

Correspondence should be addressed to Harsh Kanhere

Received 26 September 2017; Accepted 27 November 2017; Published 14 January 2018

Academic Editor: Theodore D. Liakakos

Copyright © 2018 Harsh Kanhere et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, “Global cancer statistics, 2002,” CA: A Cancer Journal for Clinicians, vol. 55, no. 2, pp. 74–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. Australian Institute of Health and Welfare, “Cancer in Australia 2014: Actual incidence data from 1982 to 2011 and mortality data from 1982 to 2012 with projections to 2014,” Asia-Pacific Journal of Clinical Oncology, vol. 11, no. 3, pp. 208–220, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Cunningham, W. H. Allum, S. P. Stenning et al., “Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer,” The New England Journal of Medicine, vol. 355, pp. 11–20, 2006. View at Google Scholar
  4. P. N. Post, H. De Beer, and G. H. Guyatt, “How to generalize efficacy results of randomized trials: Recommendations based on a systematic review of possible approaches,” Journal of Evaluation in Clinical Practice, vol. 19, no. 4, pp. 638–643, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. E. A. Bringeland, H. H. Wasmuth, R. Fougner, P. Mjønes, and J. E. Grønbech, “Impact of perioperative chemotherapy on oncological outcomes after gastric cancer surgery,” British Journal of Surgery, vol. 101, no. 13, pp. 1712–1720, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. E. K. Greenleaf, C. S. Hollenbeak, and J. Wong, “Trends in the use and impact of neoadjuvant chemotherapy on perioperative outcomes for resected gastric cancer: Evidence from the American College of Surgeons National Cancer,” Surgery, vol. 159, no. 4, pp. 1099–1112, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. S. V. Shrikhande, S. G. Barreto, S. D. Talole et al., “D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy,” World Journal of Surgical Oncology, vol. 11, article no. 31, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. Z.-Y. Li, F. Shan, L.-H. Zhang et al., “Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer,” World Journal of Surgical Oncology, vol. 9, article 110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Piso, U. Werner, H. Lang, P. Mirena, and J. Klempnauer, “Proximal versus distal gastric carcinoma - What are the differences?” Annals of Surgical Oncology, vol. 7, no. 7, pp. 520–525, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. H. J. F. Brenkman, L. Haverkamp, J. P. Ruurda, and R. Van Hillegersberg, “Worldwide practice in gastric cancer surgery,” World Journal of Gastroenterology, vol. 22, no. 15, pp. 4041–4048, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. Y.-Y. Liu, W.-L. Fang, F. Wang et al., “Does a higher cutoff value of lymph node retrieval substantially improve survival in patientswith advanced gastric cancer?—Time to embrace a new digit,” The Oncologist, vol. 22, no. 1, pp. 97–106, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. C. M. Volpe, D. L. Driscoll, and H. O. Douglass Jr., “Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes,” Annals of Surgical Oncology, vol. 7, no. 2, pp. 139–144, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. K. J. M. Liu, M. Loewen, M. J. Atten et al., “The survival of stage III gastric cancer patients is affected by the number of lymph nodes removed,” Surgery, vol. 134, no. 4, pp. 639–646, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. Z.-M. Wu, R.-Y. Teng, J.-G. Shen, S.-D. Xie, C.-Y. Xu, and L.-B. Wang, “Reduced lymph node harvest after neoadjuvant chemotherapy in gastric cancer,” Journal of International Medical Research, vol. 39, no. 6, pp. 2086–2095, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. L. Dikken, N. C. T. Van Grieken, P. Krijnen et al., “Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer,” European Journal of Surgical Oncology, vol. 38, no. 4, pp. 319–325, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Téoule, J. Trojan, W. Bechstein, and G. Woeste, “Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity after Gastrectomy for Gastric Cancer,” Digestive Surgery, vol. 32, no. 4, pp. 229–237, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Marshall-Webb, T. Bright, T. Price, S. K. Thompson, and D. I. Watson, “Venous thromboembolism in patients with esophageal or gastric cancer undergoing neoadjuvant chemotherapy,” Diseases of the Esophagus, vol. 30, no. 2, pp. 1–7, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. K. E. Rollins, C. J. Peters, P. M. Safranek, H. Ford, T. P. Baglin, and R. H. Hardwick, “Venous thromboembolism in oesophago-gastric carcinoma: Incidence of symptomatic and asymptomatic events following chemotherapy and surgery,” European Journal of Surgical Oncology, vol. 37, no. 12, pp. 1072–1077, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Jiang, K.-H. Yang, Q.-L. Guan, Y. Chen, P. Zhao, and J.-H. Tian, “Survival benefit of neoadjuvant chemotherapy for resectable cancer of the gastric and gastroesophageal junction,” Journal of Clinical Gastroenterology, vol. 49, no. 5, pp. 387–394, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Liao, Z.-L. Yang, J.-S. Peng, J. Xiang, and J.-P. Wang, “Neoadjuvant chemotherapy for gastric cancer: A meta-analysis of randomized, controlled trials,” Journal of Gastroenterology and Hepatology, vol. 28, no. 5, pp. 777–782, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Ychou, V. Boige, J. Pignon et al., “Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial,” Journal of Clinical Oncology, vol. 29, no. 13, pp. 1715–1721, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. C. Russell, “Comparison of neoadjuvant versus a surgery first approach for gastric and esophagogastric cancer,” Journal of Surgical Oncology, vol. 114, no. 3, pp. 296–303, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Qu and X. Qu, “The predictors of response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer,” Cancer Biomarkers, vol. 17, no. 1, pp. 49–54, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. U. T. Hacker, L. Escalona-Espinosa, N. Consalvo et al., “Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: Results from the randomised phase III AVAGAST trial,” British Journal of Cancer, vol. 114, no. 8, pp. 855–862, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Becker, R. Langer, D. Reim et al., “Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: A summary of 480 cases,” Annals of Surgery, vol. 253, no. 5, pp. 934–939, 2011. View at Publisher · View at Google Scholar · View at Scopus